Index
RUT
Market Cap
4.30B
Enterprise Value
5.21B
Income
60.33M
Sales
2.18B
Book/sh
87.62
Cash/sh
12.07
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
13000
IPO
Mar 31, 1992
P/E
72.04
Forward P/E
17.79
PEG
1.68
P/S
1.97
P/B
1.96
P/C
14.26
P/FCF
20.64
EV/EBITDA
13.73
EV/Sales
2.39
Quick Ratio
1.14
Current Ratio
2.32
Debt/Eq
0.55
LT Debt/Eq
0.54
Option/Short
Yes / Yes
EPS (ttm)
2.39
EPS next Y
9.67
EPS next Q
2.16
EPS this Y
14.63%
EPS next Y
8.76%
EPS next 5Y
10.58%
EPS past 3/5Y
- -62.61%
Sales past 3/5Y
-0.68% 11.90%
EPS Y/Y TTM
886.62%
Sales Y/Y TTM
-5.82%
EPS Q/Q
875.94%
Sales Q/Q
4.44%
Insider Own
1.77%
Insider Trans
-9.14%
Inst Own
104.93%
Inst Trans
2.67%
ROA
1.50%
ROE
2.79%
ROIC
1.79%
Gross Margin
34.14%
Oper. Margin
8.05%
Profit Margin
2.76%
SMA20
4.22%
SMA50
5.65%
SMA200
15.60%
Trades
Shs Outstand
25.01M
Shs Float
24.56M
52W High
192.85 -10.75%
52W Low
113.37 51.81%
Volatility
5.46% 3.58%
ATR (14)
6.60
RSI (14)
58.65
Beta
0.86
Rel Volume
1.78
Avg Volume
261.24K
Volume
464,873
Perf Week
5.09%
Perf Month
9.50%
Perf Quarter
-5.65%
Perf Half Y
36.13%
Perf YTD
20.64%
Perf Year
32.73%
Perf 3Y
68.74%
Perf 5Y
-28.63%
Perf 10Y
23.64%
Prev Close
167.65
Price
172.11
Change %
2.66%
Analysts 11 incl. previous ratings
Rating Distribution 9 Buy · 2 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Jun 15, 2026 Initiated B BTIG Research
Buy $170 -1.2% May 27, 2026 Upgrade N Needham
Hold → Buy $165 -4.1% Aug 15, 2025 Initiated P Piper Sandler
Overweight $145 -15.8% Mar 12, 2025 Upgrade R Raymond James
Outperform → Strong Buy $205 → $197 +14.5% Dec 11, 2024 Upgrade J Jefferies
Hold → Buy $200 +16.2% Oct 14, 2024 Initiated J Jefferies
Hold $183 +6.3% Jun 21, 2024 Initiated N Needham
Hold Jun 17, 2024 Upgrade R Raymond James
Mkt Perform → Outperform $135 -21.6% Nov 08, 2022 Downgrade R Raymond James
Outperform → Mkt Perform Mar 31, 2020 Upgrade C CJS Securities
Market Perform → Market Outperform Mar 18, 2020 Upgrade K KeyBanc Capital Markets
Sector Weight → Overweight $206 +19.7% Aug 08, 2019 Downgrade R Raymond James
Strong Buy → Outperform Oct 17, 2017 Initiated K KeyBanc Capital Mkts
Sector Weight Jun 20, 2017 Downgrade S Sidoti
Buy → Neutral Mar 11, 2016 Initiated G Gabelli & Co
Buy $128 -25.6% Nov 06, 2015 Reiterated R ROTH Capital
Buy $124 → $130 -24.5% Aug 11, 2015 Reiterated R ROTH Capital
Buy $102 → $124 -28.0% May 06, 2015 Reiterated R ROTH Capital
Buy $96 → $102 -40.7% Feb 10, 2015 Reiterated R ROTH Capital
Buy $82 → $96 -44.2% Nov 11, 2014 Upgrade R ROTH Capital
Neutral → Buy $56 → $82 -52.4%
Show Previous Ratings
Nov-06-26 08:30AM
Nov-05-26 08:56PM
05:41PM
04:05PM
Oct-28-26 08:05PM
08:30AM
Loading…
Oct-22-26 08:30AM
Aug-27-26 08:30AM
Aug-07-26 01:11AM
Aug-06-26 05:56PM
04:05PM
Jul-23-26 08:30AM
Jul-10-26 11:31AM
Jul-09-26 08:30AM
May-07-26 05:07PM
04:05PM
08:30AM
Loading…
Apr-23-26 08:30AM
Mar-03-26 07:24PM
Feb-23-26 08:30AM
Feb-20-26 03:58AM
12:04AM
Feb-19-26 10:07PM
06:30PM
05:50PM
05:20PM
05:07PM
(Associated Press Finance)
04:05PM
Feb-17-26 10:04PM
Feb-13-26 08:57PM
Feb-05-26 08:30AM
Jan-22-26 09:21PM
11:31PM
Loading…
Jan-15-26 11:31PM
07:49AM
Dec-31-25 08:30AM
Dec-15-25 11:03PM
Nov-27-25 10:31PM
Nov-20-25 08:30AM
Nov-13-25 12:35AM
Nov-07-25 01:11PM
11:46AM
09:28AM
12:02AM
Nov-06-25 07:00PM
06:03PM
(Associated Press Finance)
04:17PM
04:05PM
Nov-05-25 06:25PM
Nov-04-25 10:12PM
Oct-29-25 08:50AM
Oct-27-25 11:32PM
Oct-23-25 08:30AM
Sep-05-25 12:45PM
Sep-04-25 12:43AM
Sep-01-25 09:51AM
Aug-21-25 08:30AM
Aug-15-25 09:32AM
Aug-14-25 01:35AM
Aug-11-25 09:30AM
Aug-08-25 12:21PM
09:27AM
04:33AM
Aug-07-25 06:40PM
05:33PM
(Associated Press Finance)
04:05PM
Aug-05-25 11:07PM
Aug-04-25 04:08AM
Jul-25-25 11:15AM
Jul-24-25 08:30AM
Jul-18-25 11:07AM
Jul-01-25 05:34AM
01:32AM
Jun-18-25 11:31PM
Jun-10-25 12:03AM
Jun-04-25 07:27AM
May-09-25 11:15AM
03:38AM
12:36AM
May-08-25 06:45PM
05:41PM
(Associated Press Finance)
04:05PM
May-07-25 09:54AM
04:55AM
May-01-25 08:30AM
Apr-29-25 05:59AM
Apr-24-25 08:30AM
Apr-10-25 01:20PM
(Morningstar Research)
-8.35%
Apr-09-25 06:33AM
Apr-08-25 12:04PM
Apr-07-25 08:00AM
Mar-25-25 05:03AM
Mar-24-25 08:30AM
Mar-21-25 07:04AM
Mar-07-25 08:40AM
Mar-06-25 08:02AM
Mar-03-25 07:19PM
Feb-28-25 07:28AM
(Thomson Reuters StreetEvents)
02:33AM
Feb-27-25 09:06PM
06:20PM
05:19PM
(Associated Press Finance)
05:10PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Sanzone Virginia Ruth VP, General Counsel Sep 03 '26 Sale 168.69 4,856 819,150 14,604 Sep 03 06:29 PM VIRGINIA SANZONE Officer Sep 03 '26 Proposed Sale 168.69 4,856 819,150 Sep 03 04:02 PM Bonnell Brian Michael Chief Financial Officer Sep 01 '26 Sale 175.00 6,381 1,116,675 56,062 Sep 01 05:21 PM BRIAN BONNELL Officer Sep 01 '26 Proposed Sale 175.00 6,381 1,116,675 Sep 01 04:07 PM Bonnell Brian Michael Chief Financial Officer Aug 31 '26 Sale 172.79 9,307 1,608,143 62,443 Aug 31 04:43 PM BRIAN BONNELL Officer Aug 31 '26 Proposed Sale 172.79 9,307 1,608,143 Aug 31 04:13 PM Woolson Daniel VP, GM-Infusion Capital Aug 13 '26 Sale 181.33 5,417 982,265 17,062 Aug 13 06:56 PM DANIEL WOOLSON Officer Aug 13 '26 Proposed Sale 181.33 5,417 982,265 Aug 13 04:17 PM Sousa Ben Chief Information Officer Aug 12 '26 Sale 178.32 2,250 401,209 3,076 Aug 12 04:33 PM BENJAMIN SOUSA Officer Aug 12 '26 Proposed Sale 178.32 2,250 401,209 Aug 12 04:24 PM Voigtlander Christian B. Chief Operating Officer Aug 11 '26 Sale 182.93 8,929 1,633,404 37,377 Aug 11 06:18 PM FINNEY ELISHA W Director Aug 11 '26 Sale 182.48 378 68,978 4,871 Aug 11 05:59 PM CHRISTIAN VOIGTLANDER Officer Aug 11 '26 Proposed Sale 182.93 8,929 1,633,404 Aug 11 04:32 PM ELISHA W FINNEY Director Aug 11 '26 Proposed Sale 182.48 378 68,978 Aug 11 04:11 PM DANIEL WOOLSON Officer May 22 '26 Proposed Sale 132.21 2,123 280,685 May 22 04:35 PM Woolson Daniel President May 22 '26 Sale 132.21 2,123 280,685 22,479 May 22 03:47 PM Sanzone Virginia Ruth VP, General Counsel May 14 '26 Sale 124.08 2,447 303,624 19,460 May 15 12:19 PM VIRGINIA SANZONE Officer May 14 '26 Proposed Sale 124.08 2,447 303,624 May 14 06:48 PM KENNEDY KOLLEEN T Director May 13 '26 Option Exercise 0.00 1,254 0 4,539 May 13 09:29 PM Hernandez Laurie Director May 13 '26 Option Exercise 0.00 1,254 0 4,862 May 13 09:20 PM FINNEY ELISHA W Director May 13 '26 Option Exercise 0.00 1,254 0 5,249 May 13 09:11 PM Abbey Donald Director May 13 '26 Option Exercise 0.00 1,254 0 6,004 May 13 08:52 PM Hoffmeister David F Director May 13 '26 Option Exercise 0.00 1,254 0 6,004 May 13 08:38 PM Greenberg David C. Director May 12 '26 Option Exercise 101.06 2,424 244,969 10,384 May 13 08:31 PM Greenberg David C. Director May 13 '26 Option Exercise 0.00 1,254 0 9,214 May 13 08:31 PM Greenberg David C. Director May 12 '26 Sale 122.91 2,424 297,934 7,960 May 13 08:31 PM DAVID C GREENBERG Director May 12 '26 Proposed Sale 122.91 2,424 297,934 May 12 05:39 PM Voigtlander Christian B. Chief Operating Officer Mar 15 '26 Option Exercise 0.00 14,648 0 51,154 Mar 16 04:34 PM Woolson Daniel VP, GM-Infusion Capital Mar 15 '26 Option Exercise 0.00 2,924 0 25,897 Mar 16 04:33 PM Sousa Ben Chief Information Officer Mar 15 '26 Option Exercise 0.00 1,300 0 6,044 Mar 16 04:32 PM Sanzone Virginia Ruth VP, General Counsel Mar 15 '26 Option Exercise 0.00 7,324 0 24,330 Mar 16 04:31 PM Jain Vivek Chairman and CEO Mar 15 '26 Option Exercise 0.00 21,972 0 134,106 Mar 16 04:30 PM Bonnell Brian Michael Chief Financial Officer Mar 15 '26 Option Exercise 0.00 14,648 0 76,097 Mar 16 04:28 PM Bonnell Brian Michael Chief Financial Officer Mar 08 '26 Option Exercise 0.00 71,757 0 104,364 Mar 09 04:32 PM Bonnell Brian Michael Chief Financial Officer Mar 07 '26 Option Exercise 0.00 3,522 0 33,870 Mar 09 04:32 PM Jain Vivek Chairman and CEO Mar 08 '26 Option Exercise 0.00 107,635 0 176,506 Mar 09 04:21 PM Jain Vivek Chairman and CEO Mar 07 '26 Option Exercise 0.00 5,282 0 71,790 Mar 09 04:21 PM Sousa Ben Chief Information Officer Mar 08 '26 Option Exercise 0.00 8,134 0 8,283 Mar 09 04:19 PM Sousa Ben Chief Information Officer Mar 07 '26 Option Exercise 0.00 1,409 0 1,888 Mar 09 04:19 PM Sanzone Virginia Ruth VP, General Counsel Mar 08 '26 Option Exercise 0.00 27,106 0 30,424 Mar 09 04:18 PM Sanzone Virginia Ruth VP, General Counsel Mar 07 '26 Option Exercise 0.00 2,348 0 7,804 Mar 09 04:18 PM Woolson Daniel VP, GM-Infusion Capital Mar 08 '26 Option Exercise 0.00 18,300 0 28,327 Mar 09 04:15 PM Woolson Daniel VP, GM-Infusion Capital Mar 07 '26 Option Exercise 0.00 1,585 0 12,882 Mar 09 04:15 PM Voigtlander Christian B. Chief Operating Officer Mar 08 '26 Option Exercise 0.00 71,757 0 79,421 Mar 09 04:14 PM Voigtlander Christian B. Chief Operating Officer Mar 07 '26 Option Exercise 0.00 3,522 0 9,610 Mar 09 04:14 PM DANIEL WOOLSON Officer Nov 25 '25 Proposed Sale 152.35 2,897 441,364 Nov 25 04:09 PM Woolson Daniel VP, GM-Infusion Capital Nov 25 '25 Sale 152.35 2,897 441,364 11,297 Nov 25 03:18 PM FINNEY ELISHA W Director Nov 11 '25 Option Exercise 103.76 1,285 133,332 5,280 Nov 12 10:59 AM FINNEY ELISHA W Director Nov 11 '25 Sale 140.42 1,285 180,440 3,995 Nov 12 10:59 AM Sanzone Virginia Ruth VP, General Counsel Nov 11 '25 Sale 142.34 930 132,381 5,456 Nov 12 10:55 AM VIRGINIA SANZONE Officer Nov 11 '25 Proposed Sale 142.34 930 132,381 Nov 12 10:27 AM ELISHA W FINNEY Director Nov 11 '25 Proposed Sale 140.42 1,285 180,440 Nov 12 09:05 AM
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
CEO & Chairman of the Board Mr. Vivek Jain
President Mr. Daniel Woolson
CFO & Treasurer Mr. Brian Michael Bonnell
Chief Operating Officer Mr. Christian B. Voigtlander
Corporate VP Ms. Virginia Ruth Sanzone